Patient Behavior Drives a Better Design
Learn how patient behavior can inform pharmaceutical product design, packaging and delivery to create safer, more intuitive therapies.
READ MORE
IN THE NEWS
CDMO
Hidden Contamination: What Preservative-Free Ophthalmic Patients Need to Know
Learn how Blow-Fill-Seal manufacturing supports ophthalmic sterility and why proper handling of single-use ophthalmic products is essential to preventing microbial contamination.
READ MORE
Why Reclosing a Single-Use Ophthalmic Vial Doesn’t Restore Sterility
A vial may look protected after being closed again, but sterility cannot be restored once a single-use ophthalmic vial has been opened.
READ MORE
Purpose at Scale: What “Driven by Purpose” Looks Like in Pharmaceutical Manufacturing
Ritedose explores how purpose-driven pharmaceutical manufacturing strengthens quality, innovation and patient-centered care.
READ MORE
Why Pharmaceutical Resilience Is Critical in Drug Manufacturing
Pharmaceutical resilience is essential to strengthening the U.S. drug supply chain against shortages, global dependencies, and emerging risks.
READ MORE
Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced Manufacturing
– Collaboration showcases the Ritedose Center of Excellence as a global hub for advanced manufacturing education. – The Center of Excellence serves as a cornerstone of Ritedose’s broader commitment to workforce development and industry leadership.
READ MORE
Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop
Partnership Signals Commercial Readiness and Manufacturing Strength for Groundbreaking Ophthalmic Treatment.
READ MORE
Blow-Fill-Seal: How Ritedose Is Setting the Standard in Pharmaceutical Manufacturing
Blow-Fill-Seal manufacturing is transforming sterile pharmaceutical production, and Ritedose is setting the standard through innovation, quality systems and scalable CDMO expertise.
READ MORE
How Ritedose Addresses Drug Shortages
Ritedose helps address drug shortages by using advanced sterile manufacturing and strategic partnerships to keep essential treatments available.
READ MORE
Ritedose Honored With SCbio’s 2026 Life Sciences Pinnacle Award for Organizational Contribution
South Carolina’s largest sterile CDMO recognized for visionary leadership, innovation, and community impact at SCbio’s annual Life + Science Conference.
READ MORE
South Carolina Life Sciences Momentum: Ritedose Helps Fuel a Fast-Growing Innovation Hub
Ritedose is helping shape a new era of innovation in South Carolina, where life sciences companies are scaling faster than ever before.
READ MORE
Introducing Ritedose— the Largest CDMO Specializing in Blow-Fill-Seal Technology in the US
This overview explores Ritedose, the largest U.S. pharmaceutical CDMO, and how its aseptic Blow-Fill-Seal technology supports large-scale branded and generic drug manufacturing.
READ MORE
FEATURED NEWS
RECEIVE THE LATEST NEWS
Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.